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Superior mesenteric artery aneurysms: Is presence
an indication for intervention?
W. M. Stone, MD,a M. Abbas, MD,a Kenneth J. Cherry, MD,b Richard J. Fowl, MD,a and
P. Gloviczki, MD,b Scottsdale, Ariz; and Rochester, Minn
Introduction: Although rare, superior mesenteric artery (SMA) aneurysms have a definite rupture risk. Past reports have
suggested that this risk is low, yet most investigators recommend repair in selected patients. We reviewed our experience
with 21 patients to try to determine when intervention was indicated.
Methods: A retrospective review of the medical records of all patients with SMA aneurysms at our institutions from January
1980 through December 1998 was undertaken. Only patients with true aneurysms of the SMA were included.
Results: Twenty-one patients with true SMA aneurysms were identified and included 14 males (67%) and seven females
(33%). This represents a 6.9% incidence rate of all visceral aneurysms seen at our institutions. Eight patients (38%) had
rupture at presentation, including seven of the 14 males (50%). In contrast to previous reports, only one patient (4.7%)
had an infectious etiology. Five patients were on -blocker therapy, but none were seen with rupture. However, eight of
the remaining 16 patients (50%) without -blockade had rupture. Thirteen patients (62%) had calcified aneurysms, but
all ruptures were seen in noncalcified aneurysms. Operative intervention occurred in 11 of the 21 patients (52%). All eight
patients with rupture underwent operation, including six ligations and one successful embolization, and one patient died
before completion of repair. The operative mortality rate was 37.5% for ruptured aneurysms. Elective repair included one
prosthetic graft, one excision and patch angioplasty, and one embolization, with no mortality. Ten of the 21 patients
(48%) with SMA aneurysms were observed, and all were alive and well at a mean of 67 months’ follow-up (range, 2 to 148
months).
Conclusion: SMA aneurysms are rare but appear to have a higher risk of rupture than previously reported. Male patients
and patients with noncalcified aneurysms appear to have a greater risk of rupture. -Blockade may have some protective
effect against aneurysm rupture. Intervention is reasonable in all patients at good operative risk with SMA aneurysms,
considering the high rupture rate in our series. (J Vasc Surg 2002;36:234-7.)
Aneurysmal degeneration of the superior mesenteric
artery (SMA) occurs infrequently, but when it does occur,
mesenteric ischemia or aneurysm rupture may result. Al-
though varying reports of thrombosis and rupture rates
have been published by multiple authors, these events do
not appear to be uncommon. Some authors, however,
consider the risk of rupture of these aneurysms to be quite
small.1 These aneurysms remain rare but are being more
frequently encountered with the increasing use of cross-
sectional diagnostic imaging. Thus, not only are SMA
aneurysms more frequently encountered, but the dilemma
of optimal therapeutic options has become increasingly
important.
Many authors have attempted to identify the potential
risk for rupture of SMA aneurysms, but with such small
groups of patients, the rupture risk has remained elusive.
Concomitantly, historical reports of SMA aneurysms have
cited a high incidence rate of infectious etiologies, whereas
more recent series have found few such aneurysms.2 To
assist with identifying those factors associated with in-
creased risk of rupture, and in an attempt to delineate
indications for intervention, we undertook a review of our
experience.
METHODS
A retrospective review of all patients with the diagnosis
of visceral artery aneurysm at Mayo Clinic Rochester, Mayo
Clinic Jacksonville, and Mayo Clinic Scottsdale from Janu-
ary 1980 through December 1998 was undertaken. All
patients with true visceral artery aneurysms were included
for review and represent our study group. All patients
included for review had confirmational imaging studies that
verified the diagnosis. Excluded from review were those
patients with pseudoaneurysms and those with thoracoab-
dominal aneurysms involving the visceral vessels. Chart
review of all patients was undertaken, with particular atten-
tion to demographics, comorbidities, aneurysm character-
istics, clinical presentation, diagnostic methods, manage-
ment, and outcome. This represents a retrospective review,
and thus, management of these patients was not dependent
on a specific protocol but was based on surgeon preference
and judgement. Long-term follow-up was obtained via
chart review or direct telephone contact with the patient or
relative. The protocol for review was submitted and ap-
proved by the Mayo Foundation research institutional re-
view board.
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Demographics and comorbidities. Of 306 patients
with the diagnosis of true visceral artery aneurysm, 21 (7%)
were identified with SMA aneurysms. Of these 21 patients,
14 (67%) were male and seven (33%) were female. All
patients were white. Mean age at presentation was 58.8
years of age (range, 20 to 81 years). Eight patients (38%)
had aneurysm rupture at presentation. Of these eight pa-
tients with ruptured aneurysms, seven (88%) were male and
one (12%) was female. Of the 14 male patients in our series,
seven (50%) had ruptured aneurysms. Mean age at presen-
tation in patients with rupture was 63.3 years (range, 55 to
76 years) and in those without rupture was 54 years (range,
20 to 81 years; P not significant). All atherosclerotic risk
factors and comorbidities were similar in patients with
ruptured aneurysms compared with those without rupture.
This includes presence of coronary artery disease, hyperten-
sion, diabetes, hypercholesterolemia, cirrhosis, endocardi-
tis, chronic obstructive pulmonary disease, peptic ulcer
disease, obesity, and pancreatitis. Five patients (24%) were
on -blocker therapy at the time of diagnosis, and none
were seen with rupture or were found to rupture during the
follow-up period. Only one patient (5%) was on estrogen
replacement therapy. This patient was the only female
patient with a ruptured aneurysm. No statistical difference
was found between patients with rupture and those with
intact aneurysms when comparing steroid usage, history of
malignant disease, tobacco history, or family history of
aneurysmal disease. Concomitant aneurysmal disease was
seen in seven patients (33%), including thoracic, abdominal
aortic, renal, and cerebral aneurysms.
Clinical presentation and diagnosis. Of the 13 pa-
tients with intact aneurysms, three (14%) had abdominal
pain but not rupture. The remaining 10 patients (48%)
were asymptomatic at the time of initial presentation. Of
the eight patients with ruptured aneurysms, four (50%) had
bleeding with hemodynamic instability and four (50%)
were bleeding yet remained hemodynamically stable. Two
of the eight patients with rupture (25%) had concomitant
symptoms of bowel ischemia at initial presentation. One of
the patients with rupture (12%) had hematochezia. No
patient in our series had primary thrombosis of the aneu-
rysm.
Multiple imaging methods were used in establishing
the diagnosis in these patients. The diagnosis was most
commonly established with angiography. Computerized
tomographic scan first was used to establish the diagnosis in
six patients (28%). An additional nine patients (43%) had
the diagnosis established with angiography. Plain abdomi-
nal radiographs (one patient), ultrasonography (three pa-
tients), and barium enema (one patient) also were used to
establish the diagnosis in these patients. One patient (5%)
had the diagnosis established at abdominal exploration for
hemorrhage.
Aneurysm characteristics. Seventeen patients with
SMA aneurysm (81%) were found to have a solitary aneu-
rysm. Four patients (19%) had two aneurysms. One of the
four patients (25%) with two aneurysms had aneurysm
rupture at presentation. Thirteen patients (62%) had calci-
fied SMA aneurysms, but all ruptures were seen in noncal-
cified aneurysms. Laminated thrombus was identified in
aneurysms of three patients (14%). None of the patients
with laminated thrombus within the aneurysm had throm-
bosis or rupture develop. Only one patient (5%) had an
infectious etiology with Streptococcus as the final bacterium
identified. Other etiologies included atherosclerosis in two
patients (10%), cystic medial dysplasia in two patients
(10%), collagen vascular disorder in two patients (10%),
and polyarteritis nodosa in two patients (10%). The remain-
ing 11 patients (52%) had an unknown etiology for their
aneurysmal degeneration. Speculation of an atherosclerotic
etiology was entertained in each of these cases, but most
were believed to be a secondary process in these aneurysms.
Aneurysm size was not documented on any aneurysm
with rupture. On extensive review of patient records, no
accurate documentation of the size existed. The mean size
of the nonruptured group was 2.2 cm (range, 1.0 to 3.0
cm). Aneurysm characteristics, including size, etiology, and
presence of calcification or thrombus, were not statistically
different when comparing male patients with female pa-
tients.
Interventional management and outcome. The de-
cision to intervene in patients with SMA aneurysms was
dependent on surgeon preference and judgement. No spe-
cific protocol for management of these patients was fol-
lowed. All eight patients with ruptured aneurysms under-
went intervention; however, three deaths occurred. These
interventions included six ligations (75%) and one success-
ful transcatheter embolization (12%), and one patient
(12%) died before completion of the operative procedure.
Two of the six patients who underwent ligation died. The
operative mortality rate in this group with ruptured aneu-
rysms was 38%. All deaths were noted to have occurred in
those patients with ruptured aneurysms with hemodynamic
instability. None of the deaths were believed to be related
to ongoing bowel ischemia. Three patients (38%) under-
went bowel resection in conjunction with the intervention
for their SMA aneurysm. All of these patients had evidence
of bowel ischemia at initial exploration (before SMA liga-
tion).
Intervention was performed electively in eight of the 13
patients (62%) with nonruptured aneurysms. Intervention
in this group included four ligations (50%), two transcath-
eter embolizations (25%), and two prosthetic grafts (25%).
A prosthetic graft was not used for revascularization in the
patient with an infectious etiology. Bowel resection was not
necessitated in any patient who underwent elective inter-
vention. Seven of the eight patients (88%) in the electively
operated group had symptoms and/or documentation of
enlargement of their aneurysm. There was no operative
mortality, but one patient (25%) had a myocardial infarc-
tion after surgery. All patients who survived intervention
were found to be alive and well without recurrence of
aneurysmal degeneration at follow-up. No patient had
symptoms of mesenteric ischemia develop in the follow-up
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period; however, none had imaging available to document
bypass patency. Mean follow-up period in the group un-
dergoing intervention was 56 months (range, 1 to 226
months).
Nonoperative management and outcome. Nonop-
erative management was chosen in five patients (24%). The
decision to observe was primarily related to operative risk
and perceived risk of aneurysm rupture. The surgeon eval-
uating the patient did not follow a specific protocol for
management. Mean size in the nonoperated group was 1.8
cm (range, 1.0 to 2.4 cm). Although the largest observed
aneurysm was 2.4 cm, the other four aneurysms were quite
small (1.5 cm). Four of these five patients without oper-
ation (80%) had imaging studies in follow-up, including
computerized tomographic scan in three patients (60%)
and ultrasound scan in one patient (20%). No interval
growth was identified in this group of patients in follow-up.
No additional aneurysm formation was identified in these
patients in follow-up. All patients in the nonoperative
group had solitary aneurysms. All patients were found to be
alive and well without complications of the aneurysm in
follow-up. Mean follow-up period was 67 months (range, 2
to 147 months).
DISCUSSION
SMA aneurysms are the third most commonly encoun-
tered visceral artery aneurysm.3 An infectious etiology has
historically been the most common cause of these. Strepto-
coccus infections have been most common, with multiple
bacteria isolated and reported. However, more contempo-
rary series have shown infection to be uncommon.2 Only
one patient (5%) in our series was thought to have infection
as the primary cause, and the etiology of the aneurysm in
the remaining patients closely matches more contemporary
reports. This evolution in etiology may be responsible for
the wide range of reported rupture risks. This variability in
the reported rupture risk has made the decision for elective
intervention somewhat difficult to determine. Our rupture
rate in this small selective series was 38%. This is higher than
that reported in the literature and may be related to our
tertiary referral practice.3 Alternatively, it may be argued
that the true rupture risk is even higher because our practice
may include a number of patients referred for management
of their intact aneurysms. However, in our series, male
patients appeared to be particularly prone to rupture, with
50% of all male patients with ruptured aneurysms. Unfor-
tunately, because of small numbers, no preoperative factor,
including comorbidities and aneurysm characteristics, was
found to be statistically significant in prediction of rupture
risk. Thrombosis of these aneurysms also has been reported
to be a common occurrence, yet no patient in our series had
primary thrombosis of an SMA aneurysm.4
The etiology of these aneurysms in more recent series
implicates atherosclerosis as the most common pathologic
finding. However, most authors believe that this finding is
a secondary process.2 Our review revealed a wide array of
etiologies, and we concur that atherosclerosis is likely a
secondary event in these patients. However, it was the most
common pathologic finding in the SMA aneurysms in our
series. Our series also consisted of four patients (19%) with
collagen vascular disorders or polyarteritis nodosa. Sys-
temic lupus erythematosus, Bec¸het’s syndrome, cystic me-
dial necrosis, and neurofibromatosis also have been seen in
association with these aneurysms. Trauma and arterial dis-
sections have been reported but are quite rare.4,5
Most authors have reported a high incidence rate of
symptoms in these patients, including symptoms of mesen-
teric ischemia and upper abdominal pain.6 However, 10
patients (48%) in our series were asymptomatic. The diag-
nostic test of choice in these patients has been CT scan. CT
scan assists with establishing the diagnosis and establishing
whether rupture has occurred. Ultrasonography also may
be used to establish the diagnosis but would be of limited
benefit in patients with symptoms. Plain films may be
suggestive of the diagnosis but are not specific and could
represent other pathologic processes.
Intervention in these patients should be performed
selectively. Certainly, when rupture occurs, intervention is
warranted. In our group of eight patients with rupture, all
underwent intervention. This included ligation in most
(75%). However, three of the eight patients with rupture
(38%) needed concomitant bowel resection. Intraoperative
assessment of bowel perfusion included visual inspection,
insonation of Doppler signals, intravenous fluoroscein ad-
ministration, and second look exploration. No patient who
underwent elective intervention needed bowel resection.
Most historic series, including the first successful operative
intervention for SMA aneurysm, recommend ligation of
the aneurysm with assessment of bowel viability.7,8 Revas-
cularization was recommended only if bowel ischemia was
present in patients undergoing operation for rupture or if
preoperative symptoms or evaluation suggested mesenteric
ischemia. Most reported series have found that adequate
collateral visceral blood flow exists, and ligation without
revascularization is the procedure of choice.8 Adequate
collateral visceral flow is closely related to the location of
the aneurysm, and therefore, this procedure of choice may
be guided by this anatomic consideration. Only two pa-
tients (25%) of those who underwent elective intervention
underwent concomitant revascularization. No patient
needed intervention for bowel ischemia after ligation or
embolization. In both cases of revascularization, the sur-
geon believed that ligation alone was not an option in light
of the preoperative angiographic findings and the intraop-
erative assessment. We therefore believe that ligation or
transcatheter embolization with revascularization on a se-
lective basis is the treatment of choice for asymptomatic
patients.
Transcatheter embolization of SMA aneurysms has
been reported in several case reports in patients with ana-
tomically conducive lesions.9 This approach is reasonable,
particularly in the hemodynamically stable patient with
rupture. Anatomy conducive to transcatheter embolization
includes aneurysms with a small neck, which are distal to
the origin of the SMA. Assessment of bowel viability is
warranted with angiographic determination of collateral
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flow if transcatheter embolization is undertaken. Careful
assessment of patient status is mandatory to ensure bowel
viability after embolization. One patient with rupture
(25%) had successful transcatheter embolization in our
series and did not have progression to bowel ischemia.
The ideal approach to management in the asymptom-
atic patient remains elusive. In our series, as with many
other series, a significant number of patients underwent
elective intervention. Eight of the 13 patients (62%) with-
out rupture underwent elective intervention in our series.
There was no mortality in this group and no subsequent
long-term disability.
Results of observation of patients with SMA aneurysms
have not been previously reported to our knowledge. In
our series, five patients (24%) were observed without any
further intervention. These patients tended to have small
aneurysms. The largest aneurysm that was observed was 2.4
cm, but the other four aneurysms were less than 1.5 cm.
When follow-up studies were obtained, no documentation
was seen of interval growth in the patients in our series
managed nonoperatively. However, some growth was seen
in patients with outside studies. All of these patients under-
went elective intervention. Only four of the five patients
observed (80%) in our series had documented imaging
studies in follow-up; therefore, broad generalizations about
the growth rates of these aneurysms cannot be made from
the results of this series.
In summary, aneurysms involving the SMA are rare
entities but carry a definite rupture risk. This risk appears to
be higher than the risks reported in some series in the
literature. Male patients appear unusually prone to rupture
compared with female patients. In our experience, it ap-
pears as though all SMA aneurysms should be considered
for repair in patients at good operative risk. Transcatheter
embolization or ligation with close assessment of bowel
viability appears to be an effective and safe method of
management for these lesions.
REFERENCES
1. Blumberg RM, David D, Skovak J. Abdominal apoplexy due to rupture
of a superior mesenteric artery aneurysm: clip aneurysmorrhaphy with
survival. Arch Surg 1974;108:223-6.
2. Stanley JC, Wakefield TW, Graham LM, Whitehouse WM, Zelenock
GB, Lindenauer SM. Clinical importance of splanchnic artery aneu-
rysms. J Vasc Surg 1986;3:836-40.
3. Stanley JC, Messina LM, Zelenock GB. Splanchnic and renal artery
aneurysms. In: Moore W, editor. Vascular surgery. A comprehensive
review. Philadelphia: Saunders; 1998. p. 473.
4. Stanley JC, Thompson NW, Fry WJ. Splanchnic artery aneurysms. Arch
Surg 1970;101:689-97.
5. Messina LM, Stanley JC. Visceral artery aneurysms. Surg Clin North
Am 1997;77:425-41.
6. Hans SS, Gordon M, Lee PT. Saccular atherosclerotic aneurysm of the
superior mesenteric artery. Arch Surg 1977;112:854-61.
7. DeBakey M, Cooley D. Successful resection of mycotic aneurysm of
superior mesenteric artery: case report and review of the literature. Am
Surg 1953;19:202-12.
8. Stanley JC. Abdominal visceral aneurysms. In: Haimovici H, editor.
Vascular emergencies. New York: Appleton-Century-Crofts; 1982. p.
395-6.
9. Stambo GW, Hallisey MJ, Gallagher JJ. Arteriographic embolization of
visceral artery pseudoaneurysms. Ann Vasc Surg 1996;10:476-80.
Submitted Oct 3, 2001; accepted Dec 19, 2001.
DISCUSSION
Dr William Stone. Thank you, Dr Stoney, for your com-
ments and very thoughtful questions. We are all certainly in-
debted to you and your work with visceral artery reconstruc-
tions over the years. I will answer the second question first and
then the other two. I don’t think we can make any definitive
statements regarding the protective effects of  blockers, but it
is an interesting observation that no patient on  blockers was
ruptured or was found to rupture in follow-up. This past June at
the AAVS meeting in Baltimore we presented our data concern-
ing splenic artery aneurysms. While these are different entities,
the findings were similar. Of the 217 patients with splenic artery
aneurysms, 31 were on  blockers and none presented ruptured
or were found to rupture in follow-up. While this suggests some
protective effect, we cannot make any definitive statement about
it.
Your other two questions I will answer together. Since this was
a retrospective review, it is really difficult to come up with criteria
that were used to influence management decisions. The manage-
ment was dependent on the physician who saw the patient and was
most assuredly multifactorial. Not all patients were seen by our
vascular surgeons, but the majority were seen by either a vascular
surgeon or a vascular medical specialist in our institution.
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